Dong-A Socio Holdings Co., Ltd. (KRX:000640)

South Korea flag South Korea · Delayed Price · Currency is KRW
100,200
-600 (-0.60%)
Apr 29, 2026, 2:20 PM KST
4.78%
Market Cap 668.18B
Revenue (ttm) 1.43T
Net Income (ttm) 90.94B
Shares Out 6.63M
EPS (ttm) 13,718.29
PE Ratio 7.35
Forward PE 7.44
Dividend 1,650.49 (1.67%)
Ex-Dividend Date Mar 11, 2026
Volume 9,410
Average Volume 15,872
Open 100,600
Previous Close 100,800
Day's Range 99,000 - 100,600
52-Week Range 91,400 - 121,845
Beta 0.11
RSI 58.32
Earnings Date Apr 27, 2026

About Dong-A Socio Holdings

Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of Stelara in Phase 3 clinical trial; DA-1241 in Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis; DA-1726 in Phase 1 clinical tri... [Read more]

Sector Healthcare
Founded 1932
Employees 83
Stock Exchange Korea Stock Exchange
Ticker Symbol 000640
Full Company Profile

Financial Performance

In 2025, Dong-A Socio Holdings's revenue was 1.43 trillion, an increase of 7.24% compared to the previous year's 1.33 trillion. Earnings were 90.94 billion, an increase of 56.74%.

Financial Statements

News

There is no news available yet.